Clinical Efficacy and Safety Analysis of Alteplase in the Treatment of Acute Ischemic Stroke Patients

In the treatment of acute ischemic stroke, alteplase plays a vital role as a thrombolytic drug, and as the social demand for it increases, its clinical application value has received increasing attention. In order to further explore the clinical efficacy and safety of alteplase in the treatment of acute ischemic stroke, the paper outlines the pathogenesis and clinical manifestations of acute ischemic stroke, and clarified the high prevalence and severity of the disease. Besides, the mechanism of action of alteplase and its clinical effect are analyzed, and it is found that it mainly dissolves thrombi, treats thrombotic diseases, reduces the risk of bleeding, and plays a significant role in emergency treatment. In addition, it compares the characteristics and advantages of alteplase with other thrombolytics, emphasizing the importance of various thrombolytic agents in medical practice through a review of relevant literature. Overall, the study aims to explore the clinical efficacy and safety of alteplase in patients with acute ischemic stroke. The results indicate that alteplase is effective in dissolving thrombi, treating thrombotic diseases and reducing the risk of bleeding. Despite certain side effects, its overall safety was still high. Therefore, alteplase shows safe and effective advantages in the treatment of acute ischemic stroke, with broad promotional value.